Likewise, anti-PD1 pembrolizumab treatment led to significant tumor growth inhibition as well as increased activity of tumor-infiltrating lymphocytes (TILs) in adrenocortical carcinoma (ACC) engrafted humanized mice. This evidence concerns the gene PDCD1 and neoplasm.